Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Philadelphia, Pennsylvania 19107


Purpose:

The purpose of this study is to determine whether the administration of PEG along with simethicone will reduce the incidence of colonic bubbles that interfere with polyp detection.


Study summary:

evaluating if simethicone is better than placebo at decreasing gas in the colon at time of colonoscopy so that it is easier for the endoscopist to see polyps


Criteria:

Inclusion Criteria: -Elective outpatients undergoing colonoscopy using split dose PEG-ELS with sodium ascorbate and ascorbic acid Exclusion Criteria: - Unable or unwilling to give informed consent - Age < 18 years - Pregnant - Breast feeding - Established or suspected gastroparesis - Pseudo-obstruction - established or suspected - Severe constipation (< 1 BM a week) - Bowel obstruction - Greater than 50% resection of colon - Chronic nausea or vomiting - Consumed > 100% standard dose of PEG-ELS (i.e. more than 2L) - G6PD deficiency - PEG allergy - Significant psychiatric illness


NCT ID:

NCT01209806


Primary Contact:

Principal Investigator
David Kastenberg, MD
Thomas Jefferson University


Backup Contact:

N/A


Location Contact:

Philadelphia, Pennsylvania 19107
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.